[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Cancer Vaccines Market Research Report Forecast 2017 to 2022

December 2017 | 129 pages | ID: C4CDB063963EN
S&P Consulting

US$ 2,480.00 US$ 3,100.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Delivery of the Report will take 2-3 working days once order is placed.

The China Cancer Vaccines Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Cancer Vaccines industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Cancer Vaccines market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:

Dendreon
GlaxoSmithKline
Merck
Sanofi
Vaccinogen
Vaxon Biotech
Vical
Aduro BioTech
Advantagene

China Cancer Vaccines Market: Product Segment Analysis
  • Type 1
  • Type 2
  • Type 3
China Cancer Vaccines Market: Application Segment Analysis
  • Application 1
  • Application 2
  • Application 3
Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 CANCER VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Vaccines
1.2 Cancer Vaccines Market Segmentation by Type
  1.2.1 China Production Market Share of Cancer Vaccines by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Cancer Vaccines Market Segmentation by Application
  1.3.1 Cancer Vaccines Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Cancer Vaccines (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON CANCER VACCINES INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Cancer Vaccines Industry

CHAPTER 3 CHINA CANCER VACCINES MARKET COMPETITION BY MANUFACTURERS

3.1 China Cancer Vaccines Production and Share by Manufacturers (2015 and 2016)
3.2 China Cancer Vaccines Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Cancer Vaccines Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Cancer Vaccines Manufacturing Base Distribution, Production Area and Product Type
3.5 Cancer Vaccines Market Competitive Situation and Trends
  3.5.1 Cancer Vaccines Market Concentration Rate
  3.5.2 Cancer Vaccines Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA CANCER VACCINES CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Cancer Vaccines Capacity, Production and Growth (2012-2017)
4.2 China Cancer Vaccines Revenue and Growth (2012-2017)
4.3 China Cancer Vaccines Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA CANCER VACCINES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Cancer Vaccines Production and Market Share by Type (2012-2017)
5.2 China Cancer Vaccines Revenue and Market Share by Type (2012-2017)
5.3 China Cancer Vaccines Price by Type (2012-2017)
5.4 China Cancer Vaccines Production Growth by Type (2012-2017)

CHAPTER 6 CHINA CANCER VACCINES MARKET ANALYSIS BY APPLICATION

6.1 China Cancer Vaccines Consumption and Market Share by Application (2012-2017)
6.2 China Cancer Vaccines Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA CANCER VACCINES MANUFACTURERS ANALYSIS

7.1 Dendreon
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 GlaxoSmithKline
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Merck
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Sanofi
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Vaccinogen
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Vaxon Biotech
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Vical
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Aduro BioTech
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 Advantagene
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 CANCER VACCINES MANUFACTURING COST ANALYSIS

8.1 Cancer Vaccines Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Cancer Vaccines

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Cancer Vaccines Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2016
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA CANCER VACCINES MARKET FORECAST (2017-2022)

12.1 China Cancer Vaccines Production, Revenue Forecast (2017-2022)
12.2 China Cancer Vaccines Production, Consumption Forecast by Regions (2017-2022)
12.3 China Cancer Vaccines Production Forecast by Type (2017-2022)
12.4 China Cancer Vaccines Consumption Forecast by Application (2017-2022)
12.5 Cancer Vaccines Price Forecast (2017-2022)

CHAPTER 13 APPENDIX

LIST OF TABLES AND FIGUES

Figure Picture of Cancer Vaccines
Figure China Production Market Share of Cancer Vaccines by Type in 2016
Table Cancer Vaccines Consumption Market Share by Application in 2016
Figure China Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2021)
Table China Cancer Vaccines Capacity of Key Manufacturers (2015 and 2016)
Table China Cancer Vaccines Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Cancer Vaccines Capacity of Key Manufacturers in 2015
Figure China Cancer Vaccines Capacity of Key Manufacturers in 2016
Table China Cancer Vaccines Production of Key Manufacturers (2015 and 2016)
Table China Cancer Vaccines Production Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Vaccines Production Share by Manufacturers
Figure 2016 Cancer Vaccines Production Share by Manufacturers
Table China Cancer Vaccines Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Cancer Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Cancer Vaccines Revenue Share by Manufacturers
Table 2016 China Cancer Vaccines Revenue Share by Manufacturers
Table China Market Cancer Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Cancer Vaccines Average Price of Key Manufacturers in 2016
Table Manufacturers Cancer Vaccines Manufacturing Base Distribution and Sales Area
Table Manufacturers Cancer Vaccines Product Type
Figure Cancer Vaccines Market Share of Top 3 Manufacturers
Figure Cancer Vaccines Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Cancer Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Cancer Vaccines Market Share (2012-2017)
Table Dendreon Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Dendreon Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Dendreon Cancer Vaccines Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Cancer Vaccines Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Cancer Vaccines Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Cancer Vaccines Market Share (2012-2017)
Table Vaccinogen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Vaccinogen Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Vaccinogen Cancer Vaccines Market Share (2012-2017)
Table Vaxon Biotech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Vaxon Biotech Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Vaxon Biotech Cancer Vaccines Market Share (2012-2017)
Table Vical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Vical Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Vical Cancer Vaccines Market Share (2012-2017)
Table Aduro BioTech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Aduro BioTech Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Aduro BioTech Cancer Vaccines Market Share (2012-2017)
Table Advantagene Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Advantagene Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Advantagene Cancer Vaccines Market Share (2012-2017)
Figure Production Revenue Share of Cancer Vaccines by Type (2012-2017)
Figure 2015 Revenue Market Share of Cancer Vaccines by Type
Table China Cancer Vaccines Price by Type (2012-2017)
Figure China Cancer Vaccines Production Growth by Type (2012-2017)
Table China Cancer Vaccines Consumption by Application (2012-2017)
Table China Cancer Vaccines Consumption Market Share by Application (2012-2017)
Figure China Cancer Vaccines Consumption Market Share by Application in 2016
Table China Cancer Vaccines Consumption Growth Rate by Application (2012-2017)
Figure China Cancer Vaccines Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Vaccines
Figure Manufacturing Process Analysis of Cancer Vaccines
Figure Cancer Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2015
Table Major Buyers of Cancer Vaccines
Table Distributors/Traders List
Figure China Cancer Vaccines Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Cancer Vaccines Revenue and Growth Rate Forecast (2017-2022)
Table China Cancer Vaccines Production, Import, Export and Consumption Forecast (2017-2022)
Table China Cancer Vaccines Production Forecast by Type (2017-2022)
Table China Cancer Vaccines Consumption Forecast by Application (2017-2022)


More Publications